BGES stock performance?

Bio-Bridge Science Inc. (BGES) news stock charts

Bio-Bridge Science Inc. (BGES/BGES.OB) Investment Summary:

Bio-Bridge Science, Inc., a development stage company, engages in the commercial development of biological products for the prevention and treatment of human infectious diseases. It develops and commercializes HIV-PV Vaccine I to prevent and treat infection by the human immunodeficiency virus (HIV) in mainland China. The company’s products under development are vaccines against HIV, cervical cancer, and colon cancer. It develops HIV vaccines for both preventive and therapeutic purposes. The company holds the license for the HIV-PV Vaccine I technology with respect to the development and sale in the territories of People's Republic of China, Japan and the United States. The license entrusts t...
www.bio-bridge-science.com
46 Employees
Founded in 2002

BIO-BRIDGE SCIENCE INC (BGES:OTC Bulletin Board Market)

LAST $1.00 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of 4:30 PM 01/13/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of BIO-BRIDGE SCIENCE INC (BGES)

OPEN
--
PREVIOUS CLOSE
$1.00
DAY HIGH
--
DAY LOW
--
52 WEEK HIGH
08/7/09 - $2.00
52 WEEK LOW
04/29/09 - $0.22
MARKET CAP
--
AVERAGE VOLUME 10 D
0.0
EPS TTM
$-0.08
SHARES OUTSTANDING
35.4M
BGES Does Not Pay Dividends
P/E TTM
--
K = Thousands  M = Millions  B = Billions

Key developments for BIO-BRIDGE SCIENCE INC (BGES)

Bio-Bridge Science Inc. Presents at Rodman & Renshaw Annual China Investment Conference, Mar-09-2010

Bio-Bridge Science Inc. Presents at Rodman & Renshaw Annual China Investment Conference, Mar-09-2010. Venue: Ballroom III, The Regent Hotel, 99 Jinbao Steet, Beijing, Beijing Province, China.

Bio-Bridge Science Announces Receipt of Business License for Bio-Bridge JRS Biosciences (Beijing) Co. Ltd., a Cell Culture Medium Subsidiary

Bio-Bridge Science Inc. announced that the company received a business license from the Beijing Administration for Industry and Commerce of the People's Republic of China ('PRC') indicating approval of the formation of Bio-Bridge JRS Biosciences (Beijing) Co. Ltd. ('Bio-Bridge JRS'). Bio-Bridge JRS, is located in Beijing, China, and is expected to commercially produce cell culture medium and related biomaterials for use in scientific research and vaccine production.

Bio-Bridge Science Inc. - Conference Presentation Call

To provide an overview of the company, a summary of its strategic plan, as well as, discuss recent events

Bio-Bridge Science Inc. financial resources

otc, otcbb, pinksheet, BGES, ob Bio-Bridge Science Inc.

BGES Competitors

Company Last Change
No competitor information is available for BGES.
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation BGES Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 32.7x
Price/Book 7.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 30.5x

BGES

 | 

BGES transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent Financial News About Bio-Bridge Science Inc.

BIO BRIDGE SCIENCE INC Files SEC form 10-K, Annual Report

Quote: We undertake no obligation publicly to release the results of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances. OVERVIEW Bio-Bridge Science, Inc. is a biotechnology company whose subsidiaries are focused on the commercial development of HIV-PV Vaccine I, HPV vaccine, colon cancer vaccine, mucosal adjuvant. Also, we sell bovine serum through our 51% owned subsidiary, XHBD. The pre-clinical testing of HIV-PV Vaccine I on laboratory ...
Read article

BIO BRIDGE SCIENCE INC Files SEC form 10-Q, Quarterly Report

Quote: and our wholly owned subsidiaries, including Bio-Bridge Science (Beijing) Co. Ltd., a Wholly-Foreign Owned Enterprise of the People's Republic of China ("Bio-Bridge (Beijing)") , Bio-Bridge Science Corporation, a Cayman Islands corporation, Bio-Bridge Science Holding Co. Ltd, a Cayman Islands corporation, Bio-Bridge Science(HK) CO. Ltd, a Hong Kong company, and Xinheng Baide Biotechnology Co. Ltd., a Chinese company. OVERVIEW Bio-Bridge Science, Inc. is a biotechnology company whose ...
Read article

BIO BRIDGE SCIENCE INC Files SEC form 10-Q/A, Quarterly Report

Quote: and our wholly owned subsidiaries, including Bio-Bridge Science (Beijing) Co. Ltd., a Wholly-Foreign Owned Enterprise of the People's Republic of China ("Bio-Bridge (Beijing)") , Bio-Bridge Science Corporation, a Cayman Islands corporation, Bio-Bridge Science Holding Co. Ltd, a Cayman Islands corporation, Bio-Bridge Science(HK) CO. Ltd, a Hong Kong company, and Xinheng Baide Biotechnology Co. Ltd., a Chinese company. OVERVIEW Bio-Bridge Science, Inc. is a biotechnology company whose ...
Read article

BIO BRIDGE SCIENCE INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review

Quote: ITEM 4.02.NON-RELIANCE ON PREVIOUSLY ISSUED FINANCIAL STATEMENTS OR ARELATED AUDIT REPORT OR COMPLETED INTERIM REVIEW. As used in this report, "we", "us", "our", "the Company" or "BGES" refer to Bio-Bridge Science, Inc., a Delaware corporation and its subsidiaries. On August 10, 2009, the management of BGES (the "Company"), concluded, with the concurrence of the Company's Board of Directors, that an accounting error had been made in ...
Read article

BIO BRIDGE SCIENCE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib

Quote: Item 1.01 Entry into a Material Definitive Agreement. As used in this report, "we", "us", "our" or "BGES" refer to Bio-Bridge Science, Inc., a Delaware corporation and its subsidiaries. On June 9, 2009 Bio-Bridge Science (HK) Co., Ltd., a wholly-owned subsidiary of Bio-Bridge Science, Inc. entered into an equity joint venture contract with JR Scientific Inc., a California based manufacturer of classical and custom cell culture medium and sera products (&q...
Read article

Bio-Bridge Science Announces Receipt of Business License for Bio-Bridge JRS Biosciences (Beijing) Co., Ltd., a Cell Culture Medium Subsidiary

Quote: Bio-Bridge JRS, is located in Beijing, China,and is expected to commercially produce cell culture medium and relatedbiomaterials for use in scientific research and vaccine production.Bio-Bridge JRS will complement Bio-Bridge Science’s previous acquisitionof Xinheng Baide Biotechnology Co., Ltd., a serum manufacturing company,by strengthening the Company’s position as a vaccine-relatedbiomaterials supplier in the PRC.“We are pleased to receive the business license indicating a...
Read article

Would you like to leave a comment about Bio-Bridge Science Inc. BGES/BGES.OB

Besides Bio-Bridge Science Inc.'s Stock there is more great penny stock and market information at Realpennies